<DOC>
	<DOCNO>NCT02461212</DOCNO>
	<brief_summary>The purpose study see HepaFat-Scan ( special sequence image do MRI ) accurately detect amount fat liver .</brief_summary>
	<brief_title>Validation HepaFat-Scan Noninvasive Measurement Steatosis Youth</brief_title>
	<detailed_description>The lead cause liver disease adult child US nonalcoholic fatty liver disease ( NAFLD ) , obesity-related liver disease closely associate metabolic syndrome . NAFLD increase risk liver disease also increase risk type II diabetes , cardiovascular disease ( CVD ) metabolic syndrome . Invasive liver biopsy consider best diagnostic tool confirm NAFLD . This study establish magnetic resonance imaging ( MRI ) / magnetic resonance spectroscopy ( MRS ) quantitative noninvasive `` virtual biopsy '' benefit health child liver diseases decrease risk improve diagnosis . Specifically , NAFLD , fat quantification protocol broadly useful future research study , include therapy NAFLD well patient diagnosis follow-up .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Boys girl age 718 year Scheduled clinically indicate liver biopsy Able undergo MRI without sedation Written inform consent parent legal guardian Written inform assent child indicate age Renal disease creatinine &gt; 2 require dialysis Metal , brace implant device compatible MRI Not willing try hold still unsedated MRI Pregnancy Failure give consent assent</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>HepaFat-Scan</keyword>
	<keyword>Liver Disease</keyword>
	<keyword>Pediatrics</keyword>
</DOC>